Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale
出版年份 2018 全文链接
标题
Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale
作者
关键词
-
出版物
Frontiers in Aging Neuroscience
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-05-28
DOI
10.3389/fnagi.2018.00138
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Decreased sAβPPβ, Aβ38, and Aβ40 Cerebrospinal Fluid Levels in Frontotemporal Dementia
- (2018) Audrey Gabelle et al. JOURNAL OF ALZHEIMERS DISEASE
- Risk of Alzheimer's Disease Biological Misdiagnosis Linked to Cerebrospinal Collection Tubes
- (2018) Armand Perret-Liaudet et al. JOURNAL OF ALZHEIMERS DISEASE
- Impact of the 2008–2012 French Alzheimer Plan on the Use of Cerebrospinal Fluid Biomarkers in Research Memory Center: The PLM Study
- (2018) Audrey Gabelle et al. JOURNAL OF ALZHEIMERS DISEASE
- Who Needs Cerebrospinal Biomarkers? A National Survey in Clinical Practice
- (2018) Anne Cécile Troussière et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid-β 42/40 Cerebrospinal Fluid Concentration Ratio in the Diagnostics of Alzheimer's Disease: Validation of Two Novel Assays
- (2018) Piotr Lewczuk et al. JOURNAL OF ALZHEIMERS DISEASE
- Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study
- (2016) Antoine Leuzy et al. BRAIN
- Performance Evaluation of an Automated ELISA System for Alzheimer’s Disease Detection in Clinical Routine
- (2016) Davide Chiasserini et al. JOURNAL OF ALZHEIMERS DISEASE
- Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes
- (2016) Hugo Marcel Johan Vanderstichele et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease
- (2016) Piotr Lewczuk et al. JOURNAL OF ALZHEIMERS DISEASE
- Utility of CSF biomarkers in psychiatric disorders: a national multicentre prospective study
- (2016) Claire Paquet et al. Alzheimers Research & Therapy
- CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
- (2016) Shorena Janelidze et al. Annals of Clinical and Translational Neurology
- Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
- (2015) Kaj Blennow et al. Alzheimers & Dementia
- Age and amyloid effects on human central nervous system amyloid-beta kinetics
- (2015) Bruce W. Patterson et al. ANNALS OF NEUROLOGY
- Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
- (2015) Sebastian Palmqvist et al. NEUROLOGY
- Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study
- (2015) Julien Dumurgier et al. Alzheimers Research & Therapy
- Cerebrospinal Fluid Aβ40 Improves the Interpretation of Aβ42 Concentration for Diagnosing Alzheimer’s Disease
- (2015) Aline Dorey et al. Frontiers in Neurology
- The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
- (2014) José Luis Molinuevo et al. Alzheimers & Dementia
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles
- (2014) Sylvain Lehmann et al. Alzheimers Research & Therapy
- Evaluation of the Cerebrospinal Fluid Amyloid-�1-42/Amyloid-�1-40 Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders
- (2013) Magdalena Nutu et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Impact of cerebro-spinal fluid biomarkers of Alzheimer’s disease in clinical practice: a multicentric study
- (2013) François Mouton-Liger et al. JOURNAL OF NEUROLOGY
- Exacerbated CSF abnormalities in younger patients with Alzheimer's disease
- (2013) Julien Dumurgier et al. NEUROBIOLOGY OF DISEASE
- A prediction model to calculate probability of Alzheimer’s disease using cerebrospinal fluid biomarkers
- (2012) Petra E. Spies et al. Alzheimers & Dementia
- Intersite variability of CSF Alzheimer’s disease biomarkers in clinical setting
- (2012) Julien Dumurgier et al. Alzheimers & Dementia
- Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update
- (2012) Marta del Campo et al. Biomarkers in Medicine
- Cerebrospinal Fluid Collection Tubes: A Critical Issue for Alzheimer Disease Diagnosis
- (2012) A. Perret-Liaudet et al. CLINICAL CHEMISTRY
- Age and diagnostic performance of Alzheimer disease CSF biomarkers
- (2012) N. Mattsson et al. NEUROLOGY
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
- (2011) N. S. M. Schoonenboom et al. NEUROLOGY
- Added diagnostic value of CSF biomarkers in differential dementia diagnosis
- (2009) Nathalie Le Bastard et al. NEUROBIOLOGY OF AGING
- Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
- (2007) Sebastiaan Engelborghs et al. NEUROBIOLOGY OF AGING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started